These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 17917114)
21. Expression of TWEAK/Fn14 in neuroblastoma: implications in tumorigenesis. Pettersen I; Baryawno N; Abel F; Bakkelund WH; Zykova SN; Winberg JO; Moens U; Rasmuson A; Kogner P; Johnsen JI; Sveinbjörnsson B Int J Oncol; 2013 Apr; 42(4):1239-48. PubMed ID: 23443741 [TBL] [Abstract][Full Text] [Related]
22. TWEAK/Fn14 promotes the proliferation and collagen synthesis of rat cardiac fibroblasts via the NF-кB pathway. Chen HN; Wang DJ; Ren MY; Wang QL; Sui SJ Mol Biol Rep; 2012 Aug; 39(8):8231-41. PubMed ID: 22555979 [TBL] [Abstract][Full Text] [Related]
23. Antibody-based soluble and membrane-bound TWEAK mimicking agonists with FcγR-independent activity. Zaitseva O; Hoffmann A; Löst M; Anany MA; Zhang T; Kucka K; Wiegering A; Otto C; Wajant H Front Immunol; 2023; 14():1194610. PubMed ID: 37545514 [TBL] [Abstract][Full Text] [Related]
24. FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK. Chorianopoulos E; Heger T; Lutz M; Frank D; Bea F; Katus HA; Frey N Basic Res Cardiol; 2010 Mar; 105(2):301-13. PubMed ID: 19629561 [TBL] [Abstract][Full Text] [Related]
25. Intracerebroventricular administration of TNF-like weak inducer of apoptosis induces depression-like behavior and cognitive dysfunction in non-autoimmune mice. Wen J; Chen CH; Stock A; Doerner J; Gulinello M; Putterman C Brain Behav Immun; 2016 May; 54():27-37. PubMed ID: 26721417 [TBL] [Abstract][Full Text] [Related]
27. Role of the TWEAK/Fn14 pathway in autoimmune diseases. Xu WD; Zhao Y; Liu Y Immunol Res; 2016 Feb; 64(1):44-50. PubMed ID: 26659091 [TBL] [Abstract][Full Text] [Related]
28. TWEAK/Fn14 interaction induces proliferation and migration in human airway smooth muscle cells via activating the NF-κB pathway. Zhu C; Zhang L; Liu Z; Li C; Bai Y J Cell Biochem; 2018 Apr; 119(4):3528-3536. PubMed ID: 29143982 [TBL] [Abstract][Full Text] [Related]
29. Tumour necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor Fn14 during cardiac remodelling in rats. Mustonen E; Säkkinen H; Tokola H; Isopoussu E; Aro J; Leskinen H; Ruskoaho H; Rysä J Acta Physiol (Oxf); 2010 May; 199(1):11-22. PubMed ID: 20082609 [TBL] [Abstract][Full Text] [Related]
31. TWEAK/Fn14 signaling in tumors. Hu G; Zeng W; Xia Y Tumour Biol; 2017 Jun; 39(6):1010428317714624. PubMed ID: 28639899 [TBL] [Abstract][Full Text] [Related]
32. TWEAK/Fn14 pathway: a nonredundant role in intestinal damage in mice through a TWEAK/intestinal epithelial cell axis. Dohi T; Borodovsky A; Wu P; Shearstone JR; Kawashima R; Runkel L; Rajman L; Dong X; Scott ML; Michaelson JS; Jakubowski A; Burkly LC Gastroenterology; 2009 Mar; 136(3):912-23. PubMed ID: 19109961 [TBL] [Abstract][Full Text] [Related]
33. TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalpha. Vince JE; Chau D; Callus B; Wong WW; Hawkins CJ; Schneider P; McKinlay M; Benetatos CA; Condon SM; Chunduru SK; Yeoh G; Brink R; Vaux DL; Silke J J Cell Biol; 2008 Jul; 182(1):171-84. PubMed ID: 18606850 [TBL] [Abstract][Full Text] [Related]
34. Pathological activation of canonical nuclear-factor κB by synergy of tumor necrosis factor α and TNF-like weak inducer of apoptosis in mouse acute colitis. Dohi T; Kawashima R; Kawamura YI; Otsubo T; Hagiwara T; Amatucci A; Michaelson J; Burkly LC Cytokine; 2014 Sep; 69(1):14-21. PubMed ID: 25022957 [TBL] [Abstract][Full Text] [Related]
35. TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells. Ando T; Ichikawa J; Wako M; Hatsushika K; Watanabe Y; Sakuma M; Tasaka K; Ogawa H; Hamada Y; Yagita H; Nakao A Arthritis Res Ther; 2006; 8(5):R146. PubMed ID: 16945157 [TBL] [Abstract][Full Text] [Related]
36. TWEAK and Fn14: new molecular targets for cancer therapy? Winkles JA; Tran NL; Berens ME Cancer Lett; 2006 Apr; 235(1):11-7. PubMed ID: 15885893 [TBL] [Abstract][Full Text] [Related]
37. Mcl-1 mediates TWEAK/Fn14-induced non-small cell lung cancer survival and therapeutic response. Whitsett TG; Mathews IT; Cardone MH; Lena RJ; Pierceall WE; Bittner M; Sima C; LoBello J; Weiss GJ; Tran NL Mol Cancer Res; 2014 Apr; 12(4):550-9. PubMed ID: 24469836 [TBL] [Abstract][Full Text] [Related]
38. Fn14-Fc suppresses germinal center formation and pathogenic B cells in a lupus mouse model via inhibition of the TWEAK/Fn14 Pathway. Min HK; Kim SM; Park JS; Byun JK; Lee J; Kwok SK; Park YW; Cho ML; Park SH J Transl Med; 2016 Apr; 14():98. PubMed ID: 27098560 [TBL] [Abstract][Full Text] [Related]
39. Pro-inflammatory effect of TWEAK/Fn14 interaction on human umbilical vein endothelial cells. Harada N; Nakayama M; Nakano H; Fukuchi Y; Yagita H; Okumura K Biochem Biophys Res Commun; 2002 Dec; 299(3):488-93. PubMed ID: 12445828 [TBL] [Abstract][Full Text] [Related]